Baseline Albumin-Bilirubin grade as a predictor of response and outcome of regorafenib therapy in patients with hepatocellular carcinoma: a systematic review and meta-analysis.
Saved in:
| Title: | Baseline Albumin-Bilirubin grade as a predictor of response and outcome of regorafenib therapy in patients with hepatocellular carcinoma: a systematic review and meta-analysis. |
|---|---|
| Authors: | Xu, Huilin1 (AUTHOR) xhlcdd@163.com, Cao, Dedong2 (AUTHOR), Zhou, Dingjie2 (AUTHOR), Zhao, Nan2 (AUTHOR), Tang, Xixian2 (AUTHOR), Shelat, Vishalkumar G.3 (AUTHOR), Samant, Hrishikesh4 (AUTHOR), Satapathy, Sanjaya K.5 (AUTHOR), Tustumi, Francisco6 (AUTHOR), Aprile, Giuseppe7 (AUTHOR), He, Anbing1 (AUTHOR), Xu, Ximing2 (AUTHOR), Ge, Wei8 (AUTHOR) |
| Source: | BMC Cancer. 10/19/2023, Vol. 23 Issue 1, p1-10. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
